Advertisement

Table of Contents

August 01, 1986; Volume 30,Issue 2

You have access
Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
P Puttfarcken, L L Werling, S R Brown, T E Cote and B M Cox

Molecular Pharmacology August 1986, 30 (2) 81-89;
You have access
Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
L L Werling, S R Brown, P Puttfarcken and B M Cox

Molecular Pharmacology August 1986, 30 (2) 90-95;
You have access
Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
A B Norman and I Creese

Molecular Pharmacology August 1986, 30 (2) 96-103;
You have access
Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
K A Neve and P B Molinoff

Molecular Pharmacology August 1986, 30 (2) 104-111;
You have access
Inhibition of chemotactic factor-activated Na+/H+ exchange in human neutrophils by analogues of amiloride: structure-activity relationships in the amiloride series.
L Simchowitz and E J Cragoe

Molecular Pharmacology August 1986, 30 (2) 112-120;
You have access
Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
J O Marcusson, I T Bäckström and S B Ross

Molecular Pharmacology August 1986, 30 (2) 121-128;
You have access
Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes.
M A Poli, T J Mende and D G Baden

Molecular Pharmacology August 1986, 30 (2) 129-135;
You have access
Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
J M Karle, K H Cowan, C A Chisena and R L Cysyk

Molecular Pharmacology August 1986, 30 (2) 136-141;
You have access
Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
R S Gupta

Molecular Pharmacology August 1986, 30 (2) 142-148;
You have access
Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase.
T Ueda, G E Dutschman, M G Nair, J I Degraw, F M Sirotnak and Y C Cheng

Molecular Pharmacology August 1986, 30 (2) 149-153;
You have access
Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
A Svardal, R Djurhuus and P M Ueland

Molecular Pharmacology August 1986, 30 (2) 154-158;
You have access
Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
N Cheng, R C Payne, W E Kemp and T W Traut

Molecular Pharmacology August 1986, 30 (2) 159-163;
You have access
Inhibition of multiple trans-sarcolemmal cation flux pathways by dichlorobenzamil in cultured chick heart cells.
D Kim and T W Smith

Molecular Pharmacology August 1986, 30 (2) 164-170;
You have access
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
S Jard, R C Gaillard, G Guillon, J Marie, P Schoenenberg, A F Muller, M Manning and W H Sawyer

Molecular Pharmacology August 1986, 30 (2) 171-177;
You have access
Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners.
P P Tamburini and J B Schenkman

Molecular Pharmacology August 1986, 30 (2) 178-185;
You have access
Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol.
S P Sivam, C Strunk, D R Smith and J S Hong

Molecular Pharmacology August 1986, 30 (2) 186-191;